This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.94% per year. These returns cover a period from January 1, 1988 through June 1, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
insurance: Archive
AXS Near 52-Week High: Time to Add the Stock for Better Returns?
by Zacks Equity Research
AXIS Capital gains from a well-performing specialty insurance, reinsurance, and the accident and health portfolio.
insurance
RDN Near 52-Week High: Time to Add the Stock for Better Returns?
by Zacks Equity Research
Radian Group stock is poised to gain from a growing insurance portfolio, declining claims, solid capital strength, and effective capital deployment.
insurance
Top 4 Low-PEG Value Stocks Ready to Outperform the Market
by Urmimala Biswas
Here are four low-PEG value picks, ALL, TEF, ENS and CMC, as screens take into account strong growth potential and discounted valuations.
basic-materials finance industrial-products insurance utilities
3 P&C Insurance Stocks That Have Outperformed the S&P 500 YTD
by Zacks Equity Research
Given the prospects of the Property and Casualty Insurance industry, HRTG, TRV, and HCI have the potential to generate better returns than other players.
insurance
Take the Zacks Approach to Beat the Markets: MBX Biosciences, Garrett Motion & Monster Beverage in Focus
by Santanu Roy
MBX Biosciences' sharp rally highlights how Zacks' stock recommendations outpaced broader market gains across multiple portfolios.
auto-tires-trucks business-services computers construction consumer-staples insurance medical pharmaceuticals
5 Momentum Stocks to Buy for December After a Mixed November
by Nalak Das
December momentum picks gain traction as EXPE, ALL, DDS, KGC and GMED stand out after a mixed November.
gold insurance internet-content medical retail
Buy These 5 Best Value Stocks to Make the Most of P/B Ratio
by Kinjel Shah
Discover five low P/B picks like STNE that are undervalued and show solid growth potential based on value-focused filters.
computers construction insurance pharmaceuticals
UNH Battles MCR, Optum Bandages: But the Real Wild Card is Washington
by Kaibalya Pravo Dey
UnitedHealth grapples with a surging MCR as Optum's strength steadies results while Washington's policy moves loom large.
insurance medical
How Does BRK.B's SG&A Expense Management Impact Its Profits?
by Tanuka De
BRK.B keeps SG&A in check across its diverse businesses, but its real profit drivers are its insurance business and capital deployment.
insurance
PRU Stock Trading at Discount to Industry at 7.28X: Time to Hold?
by Zacks Equity Research
Prudential Financial gains from solid asset-based businesses, strong demand for retirement products and global expansion.
insurance